Previous 10 | Next 10 |
Presentation to focus on flagship Bioflux® product for the multi-billion cardiac monitoring and diagnostic market REDWOOD CITY, CA / ACCESSWIRE / May 14, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology c...
REDWOOD CITY, CA / ACCESSWIRE / May 4, 2021 / Biotricity , Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce that it's Biotres device is a finalist in Fast Company's 2021 World Changing Ideas. The World...
Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April 14, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce another record year in its r...
AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr. Waqaas Al-Siddiq, CEO of Biotricity Inc. (OTCQB: BTCY) (“the Company”), a modern medical technology company delivering disrupti...
BTCY is a possible industry disruptor with triple-digit growth rates, but few investors know about them. The business approach of BTCY benefits both physicians and patients while lowering overall medical expenses. BTCY management is guiding for triple-digit growth for the next two...
Biotricity, Inc. (BTCY) Q3 2021 Earnings Conference Call February 11, 2021, 04:30 PM ET Company Participants Mark Forney - MKR IR Waqaas Al-Siddiq - Founder and CEO John Ayanoglou - CFO Conference Call Participants Kyle Bauser - Colliers Securities Chris Jarrous - Dunlap Equity Jeff Porter - ...
Biotricity (BTCY): FQ3 GAAP EPS of -$0.11.Revenue of $1M (+162% Y/Y)Press Release For further details see: Biotricity reports FQ3 results
REDWOOD CITY, CA / ACCESSWIRE / February 11, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to provide unaudited, preliminary financial results for its fiscal 2021 third quarter, which ended ...
REDWOOD CITY, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will discuss the highlights of its financial results for the third quarter of fiscal 2021, en...
REDWOOD CITY, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a series of closings pursuant to which it sold an aggregate gross proceeds of $9,557,500 of conver...
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...